cysteine has been researched along with medermycin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abraham, RT; Barbieri, LR; Bernan, VS; Cai, P; Ding, WD; Gibbons, JJ; Hu, YB; Huang, X; Krishnamurthy, G; Levin, JI; Lucas, J; Mansour, TS; McDonald, LA; Salaski, EJ; Toral-Barza, L; Yu, K; Zhang, WG | 1 |
Ding, WD; Eid, C; Hanna, C; Honores, E; Insaf, SS; Johnson, B; Krishnamurthy, G; Laakso, L; Levin, JI; Li, Z; Mansour, TS; McDonald, LA; Powell, D; Salaski, EJ; Shim, J; Tabei, K; Toral-Barza, L; Yamashita, A; Yu, K; Zhang, WG | 1 |
2 other study(ies) available for cysteine and medermycin
Article | Year |
---|---|
Discovery of lactoquinomycin and related pyranonaphthoquinones as potent and allosteric inhibitors of AKT/PKB: mechanistic involvement of AKT catalytic activation loop cysteines.
Topics: Adenosine Triphosphate; Allosteric Regulation; Animals; Catalysis; Cell Line, Tumor; Cysteine; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Humans; Kinetics; Naphthoquinones; Phosphorylation; Protein Biosynthesis; Protein Kinases; Proto-Oncogene Proteins c-akt; Rats; RNA Caps; Structure-Activity Relationship; Substrate Specificity; Time Factors; TOR Serine-Threonine Kinases | 2007 |
Pyranonaphthoquinone lactones: a new class of AKT selective kinase inhibitors alkylate a regulatory loop cysteine.
Topics: Alkylation; Antineoplastic Agents; Biomarkers; Cell Line, Tumor; Cell Proliferation; Cysteine; Humans; Lactones; Naphthoquinones; Oncogene Protein v-akt; Pyrans; Stereoisomerism; Structure-Activity Relationship | 2009 |